Company Filing History:
3 out of 23 
2 out of 100 
1 out of 1 
Years Active: 1992-1998
Title: Michael D. Ruff: Innovator in Avian Coccidiosis Research
Introduction
Michael D. Ruff, an accomplished inventor based in Bowie, MD, USA, has made significant contributions to the field of veterinary immunology. With a total of seven patents to his name, he has focused on innovations aimed at combating avian coccidiosis, a parasitic disease affecting poultry.
Latest Patents
Ruff's latest patents showcase his expertise in the development of innovative vaccines. One of his notable inventions, titled "Isolated Protein from Eimeria Useful as a Cross Species Vaccine," involves a cloned gene that encodes antigenic proteins, effectively binding with antibodies directed against avian coccidia. Another important invention, "Eimeria Antigenic Composition which Elicits Antibodies Against Avian," describes novel recombinant antigenic proteins and fragments that contain crucial antigenic determinants. This patent also covers the methodologies for immunizing chickens against these harmful pathogens through the use of his innovative antigenic proteins.
Career Highlights
Throughout his career, Michael D. Ruff has been associated with reputable companies in the biotechnology sector, including British Technology Group USA and Enzon, Inc. His work in these organizations has significantly advanced the understanding and management of coccidial infections, establishing him as a noted figure in the field.
Collaborations
Ruff has collaborated with esteemed colleagues such as Harry D. Danforth and Susan L. Strausberg. These partnerships have fostered a productive environment for research and innovation, ultimately benefiting the poultry industry and enhancing animal health.
Conclusion
In summary, Michael D. Ruff stands out as an influential inventor with a focus on avian coccidiosis and vaccine development. His noteworthy patents and collaborative efforts reflect his commitment to improving animal health through innovative scientific research. His contributions continue to impact the poultry industry positively, paving the way for future advancements in veterinary medicine.